Clinical	0	7
factors	9	15
associated	17	26
with	28	31
development	33	43
of	45	46
severe	48	53
-	54	54
complicated	55	65
Clostridium	67	77
difficile	79	87
infection	89	97
.	98	98

Clostridium	100	110
difficile	112	120
infection	122	130
(	132	132
CDI	133	135
)	136	136
can	138	140
cause	142	146
life	148	151
-	152	152
threatening	153	163
complications	165	177
.	178	178

Severe	180	185
-	186	186
complicated	187	197
CDI	199	201
is	203	204
characterized	206	218
by	220	221
hypotension	223	233
,	234	234
shock	236	240
,	241	241
sepsis	243	248
,	249	249
ileus	251	255
,	256	256
megacolon	258	266
,	267	267
and	269	271
colon	273	277
perforation	279	289
.	290	290

We	292	293
created	295	301
a	303	303
model	305	309
to	311	312
identify	314	321
clinical	323	330
factors	332	338
associated	340	349
with	351	354
severe	356	361
-	362	362
complicated	363	373
CDI	375	377
.	378	378

We	380	381
analyzed	383	390
data	392	395
from	397	400
1446	402	405
inpatient	407	415
cases	417	421
of	423	424
CDI	426	428
(	430	430
48	431	432
.	433	433
6	434	434
%	435	435
female	437	442
;	443	443
median	445	450
age	452	454
,	455	455
62	457	458
.	459	459
5	460	460
years	462	466
;	467	467
range	469	473
,	474	474
0	476	476
.	477	477
1	478	478
-	479	479
103	480	482
.	483	483
7	484	484
years	486	490
)	491	491
at	493	494
the	496	498
Mayo	500	503
Clinic	505	510
from	512	515
June	517	520
28	522	523
,	524	524
2007	526	529
,	530	530
to	532	533
June	535	538
25	540	541
,	542	542
2010	544	547
.	548	548

Patients	550	557
with	559	562
severe	564	569
-	570	570
complicated	571	581
CDI	583	585
(	587	587
n	588	588
 	589	589
=	590	590
487	592	594
)	595	595
were	597	600
identified	602	611
as	613	614
those	616	620
who	622	624
required	626	633
admission	635	643
to	645	646
the	648	650
intensive	652	660
care	662	665
unit	667	670
or	672	673
colectomy	675	683
,	684	684
or	686	687
died	689	692
,	693	693
within	695	700
30	702	703
days	705	708
of	710	711
CDI	713	715
diagnosis	717	725
.	726	726

Logistic	728	735
regression	737	746
models	748	753
were	755	758
used	760	763
to	765	766
identify	768	775
variables	777	785
that	787	790
were	792	795
independently	797	809
associated	811	820
with	822	825
the	827	829
occurrence	831	840
of	842	843
severe	845	850
-	851	851
complicated	852	862
CDI	864	866
in	868	869
2	871	871
cohorts	873	879
.	880	880

One	882	884
cohort	886	891
comprised	893	901
all	903	905
hospitalized	907	918
patients	920	927
;	928	928
the	930	932
other	934	938
comprised	940	948
a	950	950
subset	952	957
of	959	960
these	962	966
inpatients	968	977
who	979	981
were	983	986
residents	988	996
of	998	999
Olmsted	1001	1007
County	1009	1014
,	1015	1015
Minnesota	1017	1025
to	1027	1028
assess	1030	1035
the	1037	1039
association	1041	1051
of	1053	1054
comorbid	1056	1063
conditions	1065	1074
with	1076	1079
the	1081	1083
development	1085	1095
of	1097	1098
severe	1100	1105
-	1106	1106
complicated	1107	1117
infection	1119	1127
in	1129	1130
a	1132	1132
population	1134	1143
-	1144	1144
based	1145	1149
cohort	1151	1156
.	1157	1157

The	1159	1161
linear	1163	1168
combinations	1170	1181
of	1183	1184
variables	1186	1194
identified	1196	1205
by	1207	1208
using	1210	1214
logistic	1216	1223
regression	1225	1234
models	1236	1241
provided	1243	1250
scores	1252	1257
to	1259	1260
predict	1262	1268
the	1270	1272
risk	1274	1277
of	1279	1280
developing	1282	1291
severe	1293	1298
-	1299	1299
complicated	1300	1310
CDI	1312	1314
.	1315	1315

In	1317	1318
a	1320	1320
multivariable	1322	1334
model	1336	1340
that	1342	1345
included	1347	1354
all	1356	1358
inpatients	1360	1369
,	1370	1370
increasing	1372	1381
age	1383	1385
,	1386	1386
leukocyte	1388	1396
count	1398	1402
>	1404	1404
15	1405	1406
 	1407	1407
×	1408	1408
 	1409	1409
10	1410	1411
(	1412	1412
9	1413	1413
)	1414	1414
/	1415	1415
L	1416	1416
,	1417	1417
increase	1419	1426
in	1428	1429
serum	1431	1435
level	1437	1441
of	1443	1444
creatinine	1446	1455
>	1457	1457
1	1458	1458
.	1459	1459
5	1460	1460
-	1461	1461
fold	1462	1465
from	1467	1470
baseline	1472	1479
,	1480	1480
and	1482	1484
use	1486	1488
of	1490	1491
proton	1493	1498
pump	1500	1503
inhibitors	1505	1514
or	1516	1517
narcotic	1519	1526
medications	1528	1538
were	1540	1543
independently	1545	1557
associated	1559	1568
with	1570	1573
severe	1575	1580
-	1581	1581
complicated	1582	1592
CDI	1594	1596
.	1597	1597

In	1599	1600
the	1602	1604
secondary	1606	1614
analysis	1616	1623
,	1624	1624
which	1626	1630
included	1632	1639
only	1641	1644
patients	1646	1653
from	1655	1658
Olmsted	1660	1666
County	1668	1673
,	1674	1674
comorbid	1676	1683
conditions	1685	1694
were	1696	1699
not	1701	1703
significantly	1705	1717
associated	1719	1728
with	1730	1733
severe	1735	1740
-	1741	1741
complicated	1742	1752
CDI	1754	1756
.	1757	1757

Older	1759	1763
age	1765	1767
,	1768	1768
high	1770	1773
numbers	1775	1781
of	1783	1784
leukocytes	1786	1795
in	1797	1798
blood	1800	1804
samples	1806	1812
,	1813	1813
an	1815	1816
increased	1818	1826
serum	1828	1832
level	1834	1838
of	1840	1841
creatinine	1843	1852
,	1853	1853
gastric	1855	1861
acid	1863	1866
suppression	1868	1878
,	1879	1879
and	1881	1883
use	1885	1887
of	1889	1890
narcotic	1892	1899
medications	1901	1911
were	1913	1916
independently	1918	1930
associated	1932	1941
with	1943	1946
development	1948	1958
of	1960	1961
severe	1963	1968
-	1969	1969
complicated	1970	1980
CDI	1982	1984
in	1986	1987
hospitalized	1989	2000
patients	2002	2009
.	2010	2010

Early	2012	2016
aggressive	2018	2027
monitoring	2029	2038
and	2040	2042
intervention	2044	2055
could	2057	2061
improve	2063	2069
outcomes	2071	2078
.	2079	2079
